Iovance Biotherapeutics, Inc.
IOVA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001425205
No open-market purchases or sales by Iovance Biotherapeutics, Inc. insiders were filed in the last 90 days; 293 institutions reported holding it in 13F filings for Q2 2026, worth $1.19B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Iovance Biotherapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 230
- +13 vs. Q4 2022
- Shares held
- 205.3M
- +32.6M (+18.9%) vs. Q4 2022
- Total value
- $1.25B
- +$151.5M (+13.7%) vs. Q4 2022
- New holders
- 40
- 87 more added
- Sold out
- 27
- 66 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IOVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 293 | $1.19B |
| Q1 2026 | 286 | $943.8M |
| Q4 2025 | 263 | $713.7M |
| Q3 2025 | 253 | $462.3M |
| Q2 2025 | 255 | $379.3M |
| Q1 2025 | 303 | $798.9M |
| Q4 2024 | 302 | $1.79B |
| Q3 2024 | 286 | $2.21B |
| Q2 2024 | 295 | $1.86B |
| Q1 2024 | 273 | $3.22B |
| Q4 2023 | 236 | $1.69B |
| Q3 2023 | 228 | $970.0M |
| Q2 2023 | 219 | $1.44B |
| Q1 2023 | 230 | $1.25B |
| Q4 2022 | 218 | $1.11B |
| Q3 2022 | 242 | $1.48B |
| Q2 2022 | 238 | $1.75B |
| Q1 2022 | 248 | $2.60B |
| Q4 2021 | 246 | $2.96B |
| Q3 2021 | 244 | $3.88B |
| Q2 2021 | 234 | $4.22B |
| Q1 2021 | 252 | $4.98B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Iovance Biotherapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 1,875,500 | $11.5M | 0.02% | −1,325,400−41.4% | Reduced |
| Principal Financial Group Inc | 1,912,772 | $11.7M | 0.01% | +881,181+85.4% | Added |
| Long Focus Capital Management, LLC | 2,061,814 | $12.6M | 2.03% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2,069,371 | $12.6M | 0.00% | −266,749−11.4% | Reduced |
| Nuveen Asset Management, LLC | 2,155,542 | $13.2M | 0.00% | +808,623+60.0% | Added |
| D. E. Shaw & Co., Inc. | 2,359,951 | $14.4M | 0.02% | −1,861,809−44.1% | Reduced |
| Norges Bank | 2,440,057 | $14.9M | 0.00% | −534,800−18.0% | Reduced |
| Nikko Asset Management Americas, Inc. | 2,548,991 | $15.4M | 0.18% | −38,627−1.5% | Reduced |
| Two Sigma Investments, LP | 2,557,187 | $15.6M | 0.05% | +1,663,254+186.1% | Added |
| Sumitomo Mitsui Trust Holdings, Inc. | 2,573,091 | $15.7M | 0.01% | −14,527−0.6% | Reduced |
| MPM Oncology Impact Management LP | 2,614,977 | $16.0M | 4.15% | +465,427+21.7% | Added |
| Credit Suisse AG | 2,696,842 | $16.5M | 0.02% | +31,262+1.2% | Added |
| Franklin Resources Inc | 2,699,983 | $16.5M | 0.01% | −599,239−18.2% | Reduced |
| Balyasny Asset Management LLC | 2,735,586 | $16.7M | 0.05% | +2,731,832+72,771.2% | Added |
| Geode Capital Management, LLC | 3,039,433 | $18.6M | 0.00% | +233,052+8.3% | Added |
| Millennium Management LLC | 3,412,599 | $20.9M | 0.02% | +2,229,060+188.3% | Added |
| Citadel Advisors LLC | 3,472,031 | $21.2M | 0.02% | +1,177,989+51.3% | Added |
| Artisan Partners Limited Partnership | 3,568,706 | $21.8M | 0.04% | +832,974+30.4% | Added |
| Boxer Capital, LLC | 3,705,133 | $22.6M | 1.11% | +2,200,000+146.2% | Added |
| Price T Rowe Associates Inc | 3,755,868 | $22.9M | 0.00% | −92,863−2.4% | Reduced |
| Goldman Sachs Group Inc | 3,932,984 | $24.0M | 0.01% | +289,919+8.0% | Added |
| OrbiMed Advisors LLC | 4,707,458 | $28.8M | 0.57% | +2,700,000+134.5% | Added |
| Avoro Capital Advisors LLC | 7,020,000 | $42.9M | 0.64% | 00.0% | Unchanged |
| Morgan Stanley | 7,692,691 | $47.0M | 0.01% | +2,722,822+54.8% | Added |
| Point72 Asset Management, L.P. | 8,800,059 | $53.8M | 0.19% | +8,800,059 | New |
| MHR Fund Management LLC | 11,997,103 | $73.3M | 9.86% | 00.0% | Unchanged |
| BlackRock Inc. | 12,456,662 | $76.1M | 0.00% | +379,560+3.1% | Added |
| Vanguard Group Inc | 13,540,129 | $82.7M | 0.00% | −922,953−6.4% | Reduced |
| State Street Corp | 13,733,033 | $83.9M | 0.00% | −982,442−6.7% | Reduced |
| Perceptive Advisors LLC | 15,339,735 | $93.7M | 2.77% | +5,367,955+53.8% | Added |
| Finepoint Capital LP | 0 | $0 | 0.00% | −1,545,589−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −375,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −369,463−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −253,733−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −216,880−100.0% | Sold out |
| Monaco Asset Management SAM | 0 | $0 | 0.00% | −115,000−100.0% | Sold out |
| Guggenheim Capital LLC | 0 | $0 | 0.00% | −111,286−100.0% | Sold out |
| Kettle Hill Capital Management, LLC | 0 | $0 | 0.00% | −96,007−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −73,676−100.0% | Sold out |
| SG3 Management, LLC | 0 | $0 | 0.00% | −67,000−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −41,170−100.0% | Sold out |
| NinePointTwo Capital | 0 | $0 | 0.00% | −39,969−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −20,200−100.0% | Sold out |
| Landscape Capital Management, L.L.C. | 0 | $0 | 0.00% | −16,658−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −16,235−100.0% | Sold out |
| Sanders Morris Harris LLC | 0 | $0 | 0.00% | −16,200−100.0% | Sold out |
| Connective Portfolio Management, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −11,525−100.0% | Sold out |
| Bank of Nova Scotia | 0 | $0 | 0.00% | −11,315−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −10,669−100.0% | Sold out |
| Delphia (USA) Inc. | 0 | $0 | 0.00% | −10,587−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −1,235−100.0% | Sold out |
| Johnson Financial Group, Inc. | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Washington Trust Advisors, Inc. | 0 | $0 | 0.00% | −197−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Concord Wealth Partners | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Rothschild & Co Asset Management US Inc. | – | – | – | – | Not filed |